746 | Humans |
559 | Female |
489 | Male |
416 | Adult |
262 | Adolescent |
258 | South Africa |
232 | Middle Aged |
231 | South Africa (epidemiology) |
230 | Cape town |
217 | HIV Infections (drug therapy) |
213 | Young Adult |
178 | HIV Infections (epidemiology) |
172 | Socioeconomic Factors |
151 | Prevalence |
151 | HIV Infections (prevention & control) |
138 | Programme |
128 | Public health |
123 | HIV Infections (psychology) |
122 | Child |
120 | Anti-HIV Agents (therapeutic use) |
118 | Southern africa |
118 | Risk Factors |
115 | AIDS |
109 | HIV Infections (complications) |
103 | Sub-Saharan Africa |
100 | World health organization |
96 | Surveys and Questionnaires |
96 | Pregnancy |
91 | Cross-Sectional Studies |
86 | CD4 Lymphocyte Count |
85 | Human immunodeficiency virus |
84 | Infant |
82 | Health Knowledge, Attitudes, Practice |
77 | Rural areas |
73 | Health care |
68 | World bank |
68 | HIV Infections (virology) |
68 | HIV Infections (immunology) |
66 | Risk factors |
66 | HIV Infections (transmission) |
65 | Aged |
64 | Infection |
64 | HIV Infections (diagnosis) |
61 | Antiretroviral therapy |
60 | Child, Preschool |
58 | Rural Population |
58 | Pregnant women |
58 | African countries |
55 | Health services |
55 | Antiretroviral |
54 | Tuberculosis |
53 | Participant |
53 | Lancet |
52 | Western cape |
52 | Qualitative Research |
50 | Incidence |
49 | Viral Load |
49 | Gender |
48 | HIV Infections (mortality) |
48 | Condom |
48 | Antiviral |
48 | Antiretroviral Therapy, Highly Active |
47 | Anti-Retroviral Agents (therapeutic use) |
46 | Oxford university press |
46 | Interviews as Topic |
46 | Clinic |
46 | Child health |
46 | Blackwell publishing |
45 | High levels |
44 | Tropical medicine |
44 | Prospective Studies |
43 | Young people |
43 | International journal |
43 | Human rights |
43 | Chemotherapy |
42 | Urban areas |
42 | Human virus |
41 | Same time |
41 | Retrospective Studies |
41 | John wiley sons |
41 | Cohort Studies |
41 | African journal |
40 | Social Support |
40 | Other hand |
40 | Health workers |
39 | Zambia |
39 | Behaviour |
39 | Antiretroviral agent |
38 | Sex Factors |
38 | Healthcare |
38 | Data collection |
38 | Centre |
37 | Sexual behaviour |
37 | Medical research council |
37 | Human |
37 | Epidemiology |
37 | Acquired Immunodeficiency Syndrome (epidemiology) |
36 | Treatment Outcome |
36 | Prognosis |
36 | HIV Infections (therapy) |
36 | Global |
35 | Social Stigma |
35 | Sexual Behavior |
35 | High prevalence |
35 | Guideline |
35 | Cohort |
34 | Zimbabwe |
34 | Risk-Taking |
34 | Counseling |
33 | Uganda |
33 | Johannesburg |
33 | HIV-1 |
32 | Antiretroviral treatment |
32 | Aids epidemic |
31 | Viral load |
31 | Mortality |
31 | Many countries |
31 | Focus Groups |
31 | Clin |
30 | Systematic review |
30 | Stigma |
30 | Sexual Partners |
30 | Risk factor |
30 | Mental health |
30 | Infectious Disease Transmission, Vertical (prevention & control) |
30 | Health survey |
30 | HIV-1 (immunology) |
29 | Other words |
29 | Other studies |
29 | Opportunistic infections |
29 | Kenya |
29 | Infectious diseases |
29 | Immunodeficiency |
29 | Family members |
29 | Copyright |
29 | Age Factors |
29 | African women |
29 | AIDS-Related Opportunistic Infections (epidemiology) |
28 | Time Factors |
28 | Public sector |
28 | Private sector |
28 | Infant, Newborn |
28 | Health sciences |
28 | Health Services Accessibility |
28 | Counselling |
28 | Breastfeeding |
28 | American journal |
27 | Young children |
27 | Pretoria |
27 | Morbidity |
27 | Developing Countries |
27 | Aids care |
26 | Social science |
26 | Nigeria |
26 | HIV |
26 | Durban |
26 | Anti-HIV Agents (administration & dosage) |
26 | African context |
25 | World health organisation |
25 | Treatment |
25 | Tanzania |
25 | Sustainable |
25 | Sexual behavior |
25 | Primary health care |
25 | Poverty |
25 | Logistic Models |
25 | Lesion |
25 | Journal compilation |
25 | HIV-1 (genetics) |
25 | HIV Infections (economics) |
25 | General population |
25 | Follow-Up Studies |
25 | Africa South of the Sahara (epidemiology) |
25 | AIDS-Related Opportunistic Infections (drug therapy) |
24 | Tuberculosis (epidemiology) |
24 | Subsaharan africa |
24 | Socioeconomic status |
24 | Sexual intercourse |
24 | Sexual activity |
24 | Reproductive health |
24 | Regimen |
24 | Ndings |
24 | Human resources |
24 | Health professionals |
24 | Health policy |
24 | Family planning |
24 | Economic growth |
24 | Active antiretroviral therapy |
24 | Acquired Immunodeficiency Syndrome (psychology) |
23 | Young women |
23 | Present study |
23 | Life expectancy |
23 | Human sciences research council |
23 | Health system |
23 | Economic development |
23 | Condoms (utilization) |
23 | Community members |
23 | Case study |
23 | African children |
22 | Viral |
22 | Pulmonary tuberculosis |
22 | Prevalence rates |
22 | National institute |
22 | Median |
22 | Longitudinal Studies |
22 | Focus groups |
22 | Clinical trials |
22 | Caregivers (psychology) |
22 | Anti-HIV Agents (adverse effects) |
22 | African population |
21 | Tuberculosis (drug therapy) |
21 | Sustainable development |
21 | Social support |
21 | Sexual partners |
21 | Genotype |
21 | Aids patients |
20 | Wide range |
20 | Vertical transmission |
20 | Vaccine |
20 | Research council |
20 | Medication Adherence |
20 | Malawi |
20 | International development |
20 | Health systems |
20 | HIV Infections (pathology) |
20 | Food security |
20 | Exclusive breastfeeding |
20 | Assay |
20 | Antenatal |
19 | Urban Population |
19 | Unaids |
19 | Transm |
19 | Rural area |
19 | Prophylaxis |
19 | Prejudice |
19 | Population Surveillance |
19 | Patient Acceptance of Health Care |
19 | Other countries |
19 | Mycobacterium tuberculosis |
19 | High risk |
19 | Health status |
19 | Health Policy |
19 | HIV-1 (drug effects) |
19 | HIV Infections (blood) |
19 | Family Characteristics |
19 | Disease control |
19 | Disease Progression |
19 | Civil society |
19 | Botswana |
19 | Antenatal clinics |
19 | Aged, 80 and over |
19 | Acquired Immunodeficiency Syndrome (prevention & control) |
18 | West africa |
18 | Total number |
18 | Resource |
18 | Perinatal |
18 | Paediatric |
18 | Organisation |
18 | Multivariate Analysis |
18 | Inequality |
18 | Important role |
18 | Haart |
18 | HIV Seropositivity (epidemiology) |
18 | Focus group discussions |
18 | Disease progression |
18 | Antitubercular Agents (therapeutic use) |
18 | African patients |
17 | Study population |
17 | Stellenbosch university |
17 | Social capital |
17 | Randomised |
17 | Prevention |
17 | Physical activity |
17 | Many people |
17 | Immune |
17 | Human virus infection |
17 | Health promotion |
17 | Health facilities |
17 | Governance |
17 | Global Health |
17 | Communication |
17 | Acquired Immunodeficiency Syndrome (drug therapy) |
17 | Acquired Immunodeficiency Syndrome (complications) |
17 | Abdool karim |
16 | Tuberculosis (complications) |
16 | Substance abuse |
16 | Study participants |
16 | Social services |
16 | Social development |
16 | Sexual Behavior (statistics & numerical data) |
16 | Rural communities |
16 | Rural Population (statistics & numerical data) |
16 | Reproductive |
16 | Population studies |
16 | Odds ratio |
16 | Mortality rates |
16 | Medical research |
16 | Hypertension |
16 | High rates |
16 | Health education |
16 | HIV-1 (isolation & purification) |
16 | Drug resistance |
16 | Child transmission |
16 | Breast milk |
16 | Apartheid |
16 | Antiretroviral drugs |
16 | Animals |
16 | African society |
16 | African institute |
16 | African continent |
15 | Virol |
15 | Sexual Behavior (psychology) |
15 | Qualitative research |
15 | Policy makers |
15 | Pediatr |
15 | Nations development programme |
15 | Millennium development goals |
15 | Medication Adherence (psychology) |
15 | Marital status |
15 | London school |
15 | Limpopo province |
15 | International conference |
15 | Infrastructure |
15 | Health systems trust |
15 | Health outcomes |
15 | HIV Infections (ethnology) |
15 | Global burden |
15 | Educational Status |
15 | Data analysis |
15 | Clinical features |
15 | Case-Control Studies |
15 | Case studies |
15 | Caregiver |
15 | Cardiovascular disease |
15 | Bull world health organ |
15 | Baseline |
15 | Age Distribution |
15 | African Continental Ancestry Group |
15 | AIDS-Related Opportunistic Infections (mortality) |
15 | AIDS-Related Opportunistic Infections (microbiology) |
14 | Voluntary counselling |
14 | Traditional healers |
14 | Stereotyping |
14 | Social change |
14 | Randomised trial |
14 | Program Evaluation |
14 | Personal communication |
14 | Perinatal transmission |
14 | Patient Acceptance of Health Care (statistics & numerical data) |
14 | Patient Acceptance of Health Care (psychology) |
14 | Nutritional status |
14 | Mutation |
14 | Latin america |
14 | June |
14 | International Cooperation |
14 | Human immunodeficiency virus type |
14 | Health sector |
14 | Cohort study |
14 | Clinical trial |
14 | Cambridge university press |
14 | April |
14 | Antiretroviral Therapy, Highly Active (methods) |
14 | Acquired Immunodeficiency Syndrome (mortality) |
14 | AIDS-Related Opportunistic Infections (diagnosis) |
13 | Sputum |
13 | Social exclusion |
13 | Side effects |
13 | Sex Distribution |
13 | Service delivery |
13 | Researcher |
13 | Recent years |
13 | Provider |
13 | Pilot Projects |
13 | Past month |
13 | Palliative care |
13 | Other people |
13 | Orphan |
13 | Nevirapine |
13 | National department |
13 | Mtct |
13 | Medical care |
13 | Maternal mortality |
13 | Malaria |
13 | Major cause |
13 | Interpersonal Relations |
13 | Higher levels |
13 | Heterosexual |
13 | Health research |
13 | HIV Seropositivity (psychology) |
13 | Drug Therapy, Combination |
13 | Disclosure |
13 | Demography |
13 | Culture |
13 | Comorbidity |
13 | British journal |
13 | African |
13 | Africa |
13 | Adaptation, Psychological |
13 | AIDS-Related Opportunistic Infections (immunology) |
12 | Young adults |
12 | Workplace |
12 | White paper |
12 | Tuberculosis (mortality) |
12 | Truth Disclosure |
12 | Test results |
12 | Syndrome |
12 | Social welfare |
12 | Significant differences |
12 | Secondary school |
12 | Research team |
12 | Regression Analysis |
12 | Recent study |
12 | Randomized Controlled Trials as Topic |
12 | Quality of Life |
12 | Progression |
12 | Pneumonia |
12 | Pmtct |
12 | Pediatrics |
12 | Odds ratios |
12 | Nutr |
12 | Natural resources |
12 | Multivariate analysis |
12 | Medication |
12 | Medication Adherence (statistics & numerical data) |
12 | Maternal |
12 | International society |
12 | Infant mortality |
12 | Immunodeficiency syndrome |
12 | Human virus type |
12 | Hazard ratio |
12 | HIV Infections (physiopathology) |
12 | Free state |
12 | East africa |
12 | Disease Outbreaks |
12 | Current study |
12 | Contraceptive |
12 | Climate change |
12 | Cell count |
12 | Cause of Death |
12 | Attitude of Health Personnel |
12 | African youth |
12 | Africa South of the Sahara |
12 | Adverse effects |
12 | AIDS Vaccines (immunology) |
11 | Woman |
11 | Western cape province |
11 | Symptom |
11 | Swaziland |
11 | Susceptibility |
11 | Stis |
11 | Social security |
11 | Social justice |
11 | Sexuality |
11 | Sexual practices |
11 | Sarcoma |
11 | Regression analysis |
11 | Randomized |
11 | Qualitative study |
11 | Prospective study |
11 | Previous studies |
11 | Poverty reduction |
11 | Population council |
11 | Poor people |
11 | Pilot study |
11 | Nancial |
11 | Mass Screening |
11 | Lymphoma |
11 | Lymphocyte |
11 | Local government |
11 | Local communities |
11 | Limpopo |
11 | Limited resources |
11 | Learner |
11 | Human immunodeficiency virus infection |
11 | Human capital |
11 | Higher education |
11 | Healthcare system |
11 | Health care workers |
11 | Health Surveys |
11 | Health Services Accessibility (statistics & numerical data) |
11 | HIV-1 (physiology) |
11 | Further research |
11 | Funding |
11 | Eastern cape |
11 | Determinant |
11 | Coronary heart disease |
11 | Control group |
11 | Confidence interval |
11 | Community health workers |
11 | Caput |
11 | Capacity building |
11 | Blood pressure |
11 | Blood donors |
11 | Blackwell |
11 | Birth weight |
11 | Biopsy |
11 | Attitude to Health |
11 | Antiretroviral Therapy, Highly Active (adverse effects) |
11 | Alcohol consumption |
11 | Alcohol Drinking (epidemiology) |